These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5990238)

  • 1. [Influence of fatty meals on the behavior of serum phosphatides in diabetic and arteriosclerotic vascular disease patients].
    Piancino G; Martini PF; Barazia G; Martino P
    G Gerontol; 1966 Jul; 14(7):615-26. PubMed ID: 5990238
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of hyperlipemia and hyperglycemia induced in pateints with coronary atherosclerosis].
    Babei E; Cucu R; Cristea E; Hodan O
    Stud Cercet Med Interna; 1972; 13(5):463-72. PubMed ID: 4645063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of lipid metabolism in patients with peripheral arteriosclerosis].
    Schmidt HH; Heine H; Friedel W; Ahlert G; Jaruszewski H
    Z Gesamte Inn Med; 1968 Feb; 23(4):53-6. PubMed ID: 5686876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Atherosclerosis and diabetes. Hepatic synthesis of lipids].
    Greco AV; Mingrone G; Peruzzi E; Pepe M; Gattini G
    Recenti Prog Med; 1980 May; 68(5):543-56. PubMed ID: 7006004
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular disease in diabetes: pathophysiological mechanisms and therapy.
    Colwell JA; Halushka PV; Sarji KE; Lopes-Virella MF; Sagel J
    Arch Intern Med; 1979 Feb; 139(2):225-30. PubMed ID: 434977
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hydroxyproline indicators before and after treatment of diabetic angiopathies].
    Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Tulemisov EU; Bokaneva IA
    Ter Arkh; 1978; 50(1):93-7. PubMed ID: 635809
    [No Abstract]   [Full Text] [Related]  

  • 7. [The modification of diabetic retinopathy and pathologically changed serum lipid values by essential phospholipids].
    Hammerl H; Spiller H
    Wien Med Wochenschr; 1966 Jul; 116(27):607-11. PubMed ID: 5995261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathology of diabetic arteriosclerosis].
    Hasegawa M; Arai C; Saito M; Takeuchi K; Yamamoto K; Takayama Y; Arai K; Kosuge T; Morishita T; Shirai T
    Nihon Rinsho; 1991 Feb; 49 Suppl():43-8. PubMed ID: 2033834
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the etiopathogenesis of diabetic macroangiopathy].
    Leon A
    Med Interna (Bucur); 1973 Nov; 25(11):1375-83. PubMed ID: 4793900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a diet enriched in essential fatty acids on lipid values and composition of fatty acids in serum lipid fractions in the aged].
    Ziemlanski S; Budzynska-Topolowska J; Rdzanek J; Okolska G; Karpinska H; Klos A; Franczuk H; Dietl B; Peczak R
    Ann Nutr Aliment; 1980; 34(4):677-97. PubMed ID: 7224492
    [No Abstract]   [Full Text] [Related]  

  • 11. Indobufen induced modification of phospholipid composition in diabetic platelets.
    Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A
    Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucagon and lipid metabolism. 3. Modifications of the total blood lipids, phospholipids and hematic neutral fats due to glucagon stimulation].
    Bianucci G
    Riv Crit Clin Med; 1965 Oct; 65(5):523-39. PubMed ID: 5885542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Considerations on alimentary hyperlipemia in arteriosclerosis and its modification].
    Böhle E
    Folia Clin Int (Barc); 1966 Oct; 16(10):462-9. PubMed ID: 5995674
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the intravenous tolbutamide test (ivTT) in patients with coronary disease. (Glucide-lipid metabolic relationships)].
    Popescu P; Anghel S; Idu S; Mihai N; Moldovan T; Mihail A
    Med Interna (Bucur); 1974 Apr; 26(4):445-52. PubMed ID: 4839351
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimally oxidised LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy.
    Picard S; Talussot C; Serusclat A; Ambrosio N; Berthezène F
    Diabetes Metab; 1996 Feb; 22(1):25-30. PubMed ID: 8697292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinetics of tritium-water exchange in patients with arteriosclerotic vascular disease].
    Fleischmann HJ; Ziegler A; Rödenbeck M; Emmrich R; Marek H; Friedrich T
    Z Gesamte Inn Med; 1974 Oct; 29(20):840-6. PubMed ID: 4464713
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDY OF THE RELATION BETWEEN SUGAR CONSUMPTION AND THE ATHEROMATOUS ARTERIAL MANIFESTATIONS, ESPECIALLY MYOCARDIAL INFARCTION].
    JUSTIN BESANCON L; PEQUIGNOT H; CREMER G
    Sem Hop; 1965 Jan; 41():228-9. PubMed ID: 14293624
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R; Nadler JL
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrients and lipoproteins: dietary profiles of population groups and experimental models.
    Rabbi A
    Prog Biochem Pharmacol; 1983; 19():166-76. PubMed ID: 6338521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation between arteriosclerotic complications and changes in lipids and glycoprotein metabolism in diabetic patients].
    Palmas S; Farris A; Malavasi A; Scarpa GL
    Boll Soc Ital Cardiol; 1967; 12(6):625-40. PubMed ID: 5608618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.